Evidence map›Paper›PMID 40810968›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

Analytical comparison of 11 CE-IVD marked real-time PCR assays for Borrelia burgdorferi sensu lato detection.

Laurence Zilliox, Maximilian Faller, Lisa Baldinger, Barbara Streibl, Marine Engel, Gabriele Margos, Volker Fingerle, Benoit Jaulhac, Emilie Talagrand-Reboul

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laurence ZillioxFrench National Reference Center for Borrelia, CHRU de Strasbourg, Strasbourg, France.
Maximilian FallerGerman National Reference Center for Borrelia, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Oberschleißheim, Germany.
Lisa BaldingerFrench National Reference Center for Borrelia, CHRU de Strasbourg, Strasbourg, France.
Barbara StreiblGerman National Reference Center for Borrelia, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Oberschleißheim, Germany.
Marine EngelFrench National Reference Center for Borrelia, CHRU de Strasbourg, Strasbourg, France.
Gabriele MargosGerman National Reference Center for Borrelia, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Oberschleißheim, Germany.
Volker FingerleGerman National Reference Center for Borrelia, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Oberschleißheim, Germany.
Benoit JaulhacFrench National Reference Center for Borrelia, CHRU de Strasbourg, Strasbourg, France.
Emilie Talagrand-ReboulFrench National Reference Center for Borrelia, CHRU de Strasbourg, Strasbourg, France. talagrandreboul@unistra.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn some precise clinical manifestations of Lyme borreliosis, PCR can be helpful for diagnosis: suspicion of atypical erythema migrans, borrelial lymphocytoma, acrodermatitis chronica atrophicans, Lyme arthritis or in very early seronegative neuroborreliosis. This study aimed to evaluate: (1) the analytical sensitivity of commercial real-time PCR kits for Borrelia burgdorferi sensu lato (Bbsl), (2) their specificity, and (3) their practicability.

methodsThe performances of 11 CE-IVD marked commercial kits and the French NRC Borrelia's in-house PCR were evaluated. PCRs were performed blindly on quantified DNA extracts, from 14 Bbsl strains corresponding to eight different genospecies, and on DNAs from relapsing fever (RF) Borrelia, Treponema, Leptospira, and 26 other micro-organisms.

resultsDNAs from Bbsl strains ranging from 10 to 10

conclusionThis study shows that the analytical performance and practicability of the kits evaluated are broadly in line, but that advanced molecular biology skills are required to interpret the results. Simultaneous detection of Lyme Borreliosis and RF agents without precise distinction may result in a risk of confusion in the choice of biological matrices and in the wording of the result returned to the clinician. Diagnostic laboratories must pay particular attention to the amplification confirmation strategy.

Indexed as

Borrelia burgdorferi GroupReal-Time Polymerase Chain ReactionDNA, BacterialReagent Kits, DiagnosticSensitivity and SpecificityDNA, BacterialReagent Kits, DiagnosticBorreliaEvaluationLyme borreliosisPCR tests

Identifiers

PMID40810968
PMCPMC12619792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.